Birdwatch Note Rating
2024-01-28 23:36:06 UTC - HELPFUL
Rated by Participant: F5587D1197E3C24CCC93814D58906EAC874EDB80A6F8C86E5925407EFBA92D15
Participant Details
Original Note:
Of a total of 64 outcomes in studies of GET, NICE graded 52 (81%) as “VERY LOW” quality and 12 (19%) as “LOW” quality. It has been established that GET is not a suitable treatment for MECFS, and a significant cohort of Long Covid patients meet MECFS diagnostic criteria. https://www.nice.org.uk/guidance/gid-ng10091/documents/evidence-review-7
All Note Details